PRG4 treatment for interstitial cystitis
US9107885B2 · kind B2 · utility
14Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2010 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Mar 5, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a disorder of the lower urinary tract, and in particular, reducing the symptoms (including treatment) of interstitial cystitis in vivo. In a preferred embodiment, the present invention relates to treatment formulations and methods for reducing interstitial cystitis in patients via administration of a therapeutically effective concentration of PRG4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.